Contents
Introduction
India ranks 38th in Global Innovation Index 2025 yet spends only 0.65% of GDP on R&D. The Economic Survey 2025–26 highlights India’s improved innovation ranking, while the Union Budget 2026–27 expands RDI funding; yet NITI Aayog warns weak private R&D threatens innovation-led growth.
The Indian Innovation Paradox
India’s strong policy intent coexists with weak structural health of our Research, Development, and Innovation (RDI) ecosystem.
- R&D Intensity Gap: Gross Expenditure on R&D (GERD) stagnates at 0.65% of GDP, lowest among BRICS (except South Africa) and far below Israel (5.4%), South Korea (4.9%) and China (2.4%).
- Government measures and Unprecedented Ambitions: ₹1 lakh crore Research, Development and Innovation (RDI) Fund, Anusandhan National Research Foundation (ANRF) operationalisation, removal of three-year existence barrier for deep-tech startups, lifting atomic energy patent ban via SHANTI Act 2025, and six-fold hike in Atal Tinkering Labs funding (₹500 cr to ₹3,200 cr) — signal unprecedented ambition.
- Patent Growth but Limited Global Technological Influence: Patent filings doubled to 1,10,000 (2024-25), but domestic PCT applications (4,547 in 2024) trail China (70,000+), US (54,000+) and Japan (48,000+). For Example- India filed only around 4,500 Patent Cooperation Treaty applications in 2024, highlighting weak global technological influence.
- Human Capital and Inclusion Constraints: GII 2025 ranks India 95th in knowledge-intensive employment and 101st in women with advanced degrees in workforce, reflecting talent and diversity deficits.
- Private Sector Crowding Out: Private-sector contribution to GERD is only ~37%, compared with >70% in leading innovation economies. In India, the State bears 60% of the cost, signaling a private sector hesitant to embrace long-term, high-risk technological bets. This paradox arises from historical public-sector dominance in R&D, weak university-industry linkages, risk-averse corporate culture and insufficient patient capital for deep-tech commercialization.
- Lab-To-Market Gap: India produces significant academic research but struggles to commercialise innovation. Universities generate increasing scientific publications.
Anchoring Research to Private Enterprise
Innovation achieves transformative scale only when research is demand-driven and anchored to enterprise. Private-sector participation addresses current bottlenecks:
- Market-Pull Innovation: Firms prioritise commercially viable problems, improving resource efficiency along with curiosity-driven public research.
- Bridging the Valley of Death: Enterprise provides Series equity and venture funding and scale-up expertise to convert lab prototypes into market-ready products.
- Cross-Sectoral Synergies: Private involvement in semiconductors, green hydrogen (PLI 2.0) and 6G forces convergence of engineering, logistics and digital technologies.
- Global Technological Influence: Sustained corporate R&D increases high-quality international patents (PCT/SEPs) and standard-essential technologies, enhancing India’s voice in global rule-setting. For Example- Commercial space startups (Skyroot, Agnikul) demonstrating private-sector promise when risk capital and regulatory openness align.
- Deep-Tech and Long-Gestation Capital: Deep tech requires patient capital: funding that survives long development cycles to transform complex laboratory science into scalable, market-ready products.
Way Forward
- Mandate Industry Residency programmes for researchers and reverse sabbaticals for corporate experts in academia.
- Use public procurement as first buyer for indigenous innovations (defence, space, health) to de-risk private R&D.
- Strengthen IPR fast-tracking and create specialised deep-tech bankruptcy norms to tolerate failure.
- Expand ANRF matching grants with mandatory industry co-investment clauses.
- Launch national Innovation Anchors scheme incentivising large corporates to dedicate 1% PAT to collaborative R&D.
Conclusion
Thinking is progress. To achieve Viksit Bharat, India must pivot from labor-led delivery to R&D-driven enterprise, ensuring our demographic dividend becomes technological powerhouse.


